Non-invasive prenatal testing (NIPT) is a simple blood test during pregnancy that helps detect rare genetic conditions early, ...

A strategic partnership between Vaxxas and Profenso, an Australian AI company specialising in advanced automation for regulated industries, has been announced.

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Illumina (NASDAQ:ILMN) and its peers.

Male infertility can impact pregnancy chances more than many realise. An expert explains key causes, genetic factors, warning signs, and important tests couples should consider when trying to conceive ...

In an interview with Jay Salazar from Panther Life Sciences, we discuss microarray patch (MAP) technology and its potential ...

Infectious keratitis remains a leading cause of corneal blindness and visual impairment worldwide, with bacterial, fungal, amoebic and viral pathogens presenting major diagnostic and therapeutic ...

Methods developed and validated to establish the “World Bank of NK Cells” from healthy donors and cancer patientsSingle ...

U.S. Gene Expression Analysis Market size is USD 1.28 Billion in 2025 and is expected to reach USD 2.45 Billion by 2035 owing to high penetration of advanced molecular analysis technologies.Austin, ...

The panel ensures compatibility with our previous autosomal Family Finder tests plus all the autosomal transfers we ...

Microliter dispensing pumps deliver accurate low-volume dosing to support laboratory, diagnostic, and industrial fluid ...